Figure S5 from Loss of STK11 Suppresses Lipid Metabolism and Attenuates KRAS-Induced Immunogenicity in Patients with Non–Small Cell Lung Cancer
Year: 2024
Type: other
Abstract: Figure S5. KRAS/STK11 co-mutated tumors have an immune excluded phenotype via the xCell deconvolution algorithm
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4402070163
